Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-02-27 | Ms. Michelle D. GreeneExec. VP and Chief Information Officer of Global Technology & Business Services | -2,75k | 627,39k | Vendita | 228,47 - 228,55 | 12,23k | -18,34% |
| 2026-02-18 | Mr. Aaron E. AltCFO | -2,33k | 524,96k | Vendita | 225,50 | 0,00 | -100,00% |
| 2026-02-15 | Mr. Aaron E. AltCFO | -1,91k | 422,59k | Sale to Issuer | 220,79 | 0,00 | -100,00% |
| 2026-02-06 | Ms. Patricia Arlene Hemingway HallIndependent Chairman of the Board | -4,00k | 918,88k | Vendita | 229,72 | 10,58k | -27,44% |
| 2025-12-01 | Ms. Deborah L. WeitzmanCEO of Pharmaceutical & Specialty Solutions Segment | -551,00 | 116,96k | Sale to Issuer | 212,26 | 52,88k | -1,03% |
| 2025-12-01 | Ms. Jessica L. MayerChief Legal & Compliance Officer | -422,00 | 89,57k | Sale to Issuer | 212,26 | 12,98k | -3,15% |
| 2025-12-01 | Ms. Ola M. SnowInsider | -320,00 | 67,92k | Sale to Issuer | 212,26 | 15,25k | -2,05% |
| 2025-12-01 | Mr. Stephen M. MasonCEO of GMPD segment | -595,00 | 126,29k | Sale to Issuer | 212,26 | 25,49k | -2,28% |
| 2025-12-01 | Ms. Mary C. SchererSenior VP & CAO | -61,00 | 12,95k | Sale to Issuer | 212,26 | 3,50k | -1,72% |
| 2025-08-20 | Ms. Deborah L. WeitzmanCEO of Pharmaceutical & Specialty Solutions Segment | -21,37k | 3,22M | Vendita | 150,53 | 53,43k | -28,57% |
| 2025-08-20 | Mr. Jason M. HollarCEO & Director | -35,90k | 5,39M | Vendita | 149,40 - 150,40 | 107,40k | -25,05% |
| 2025-08-19 | Ms. Michelle D. GreeneExec. VP and Chief Information Officer of Global Technology & Business Services | -13,50k | 2,01M | Vendita | 148,76 - 149,28 | 14,98k | -47,41% |
| 2025-08-15 | Ms. Michelle D. GreeneExec. VP and Chief Information Officer of Global Technology & Business Services | -9,97k | 1,50M | Sale to Issuer | 150,22 | 14,98k | -39,96% |
| 2025-08-19 | Ms. Mary C. SchererSenior VP & CAO | -6,77k | 1,01M | Vendita | 149,25 | 3,56k | -65,55% |
| 2025-08-15 | Ms. Mary C. SchererSenior VP & CAO | -2,57k | 386,37k | Sale to Issuer | 150,22 | 3,56k | -41,97% |
| 2025-08-19 | Mr. Stephen M. MasonCEO of GMPD segment | -41,58k | 6,19M | Vendita | 147,87 - 149,39 | 26,09k | -61,45% |
| 2025-08-15 | Mr. Stephen M. MasonCEO of GMPD segment | -30,81k | 4,63M | Sale to Issuer | 150,22 | 26,09k | -54,15% |
| 2025-08-19 | Mr. Jason M. HollarCEO & Director | -107,71k | 16,04M | Vendita | 148,15 - 149,45 | 143,30k | -42,91% |
| 2025-08-15 | Mr. Jason M. HollarCEO & Director | -136,41k | 20,49M | Sale to Issuer | 150,22 | 143,30k | -48,77% |
| 2025-08-15 | Ms. Deborah L. WeitzmanCEO of Pharmaceutical & Specialty Solutions Segment | -24,13k | 3,62M | Sale to Issuer | 150,22 | 74,80k | -24,39% |
| 2025-08-19 | Ms. Jessica L. MayerChief Legal & Compliance Officer | -38,08k | 5,67M | Vendita | 148,08 - 149,52 | 27,01k | -58,50% |
| 2025-08-15 | Ms. Jessica L. MayerChief Legal & Compliance Officer | -27,93k | 4,20M | Sale to Issuer | 150,22 | 27,01k | -50,83% |
| 2025-08-19 | Ms. Ola M. SnowInsider | -28,15k | 4,19M | Vendita | 148,86 - 149,39 | 15,58k | -64,38% |
| 2025-08-15 | Ms. Ola M. SnowInsider | -18,19k | 2,73M | Sale to Issuer | 150,22 | 15,58k | -53,87% |
| 2025-08-19 | Mr. Aaron E. AltCFO | -48,24k | 7,18M | Vendita | 148,61 - 149,19 | 0,00 | -100,00% |
| 2025-08-15 | Mr. Aaron E. AltCFO | -34,87k | 5,24M | Sale to Issuer | 150,22 | 0,00 | -100,00% |
| 2025-06-30 | Mr. Stephen M. MasonCEO of GMPD segment | -5,69k | 951,92k | Sale to Issuer | 167,18 | 34,98k | -14,00% |
| 2025-06-30 | Ms. Jessica L. MayerChief Legal & Compliance Officer | -5,18k | 865,32k | Sale to Issuer | 167,18 | 29,53k | -14,91% |
| 2025-06-30 | Mr. Jason M. HollarCEO & Director | -5,82k | 973,15k | Sale to Issuer | 167,18 | 80,12k | -6,77% |
| 2025-06-30 | Ms. Ola M. SnowInsider | -3,62k | 605,69k | Sale to Issuer | 167,18 | 23,69k | -13,27% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
